このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Interaction of Social Factors With Air Pollution (SOZIAL)

2017年7月25日 更新者:David Diaz-Sanchez、Environmental Protection Agency (EPA)

Purpose:

The purpose of this protocol is to understand how social factors such as psychosocial stress may modify how people respond to air pollution. Ultimately this will help us understand health disparities from poor air quality.

Participants:

Up to 40 healthy adults,18-33 years old with different perception of stress will participate and complete this study.

Procedures (methods):

Subjects will be exposed to clean air and to ozone ( 300ppb) for 2 hours in a controlled environment chamber. Cardiac, vascular, pulmonary and cognitive function will be evaluated pre, immediately post and 18 hr post exposure.

The primary endpoint will be Heart Rate Variability . Secondary endpoints will include pulmonary function, analysis of blood clotting/coagulation factors, biomarkers of stress, cognitive function, radial artery pulse wave measurements and analysis of soluble factors present in plasma.

調査の概要

詳細な説明

Over the past decades, air quality in the U.S. has improved significantly. Even so, millions of people in the U.S. still live in counties that do not meet air quality standards for one or more pollutants. Ozone is a major component of photochemical smog and is one of the most thoroughly studied gaseous pollutants. Controlled human exposure studies have been critical in demonstrating that it can cause airway inflammation 1-3, including increases in neutrophil infiltration into the lung and the production of pro-inflammatory mediators 4,5[, and ultimately decrements in lung function [reviewed in 6]. More recent studies have shown that ozone can also increase vascular inflammation, as well as alter autonomic nervous system control of heart rate and cardiac repolarization 7. Numerous epidemiological studies have also demonstrated an association between acute and chronic exposure to ambient levels of ozone and various health effects most notably asthma 6. These studies have also highlighted a need to incorporate social and nonchemical factors into risk assessments 8. Similarly, social factors such as psychological stress are now regarded as important contributors to asthma outcomes 9,10. This protocol is aimed at investigating how stress impacts health responses to air pollutants. Since psychosocial stress-related susceptibility has been proposed to explain social disparities, this will help us understand which populations and individuals are at increased risk from air pollution.

This protocol is designed to determine whether nonchemical stressors exacerbate ozone effects. In particular we will focus on elevated psychosocial stress as it has been shown to contribute to several adverse health outcomes, most notably, to cardiovascular disease. The physiological mechanism by which psychosocial stress leads to health effects is due, at least in part, to elevated circulating glucocorticoids, or stress hormones, which are regulated by the hypothalamic-pituitary-adrenal (HPA). In the last 30 years the concept of allostasis has evolved. Allostasis is the process whereby an organism adapts to the demands of the environment. An allostatic load model applies this concept to chronic stress11. In this model the perception of threat over long time intervals (perceived stress) can cause over-activation of the HPA-axis resulting in changes in physiological systems as chemical imbalances in autonomic nervous system, central nervous system, neuroendocrine, and immune system activity. Factors such as genetics, behavior, life events and diet can impact this model. To our knowledge no clinical study has investigated the link between air pollution effects on cardiovascular disease and psychosocial stress. However, several studies have now shown an association between stress and respiratory outcomes to air pollution. Claugherty and colleagues (2007) found an association between traffic-related air pollution and asthma solely among children exposed to violence 12. Shankardass and colleagues demonstrated that children from stressful households are more susceptible to the effects of traffic-related pollution on the development of asthma 13. In that study, stress was evaluated using the Perceived Stress Scale (PSS) developed by Dr. Sheldon Cohen of Carnegie Mellon University. This is the most widely used psychological instrument for measuring the perception of stress and has been validated in multiple studies. We will use this scale to evaluate the degree to which subjects appraise situations in their life as stressful. Heart rate variability (HRV) is considered to be a reliable biomarker of stress. Chronic stress has been shown to be associated with decreases in HRV 14. Since acute ozone exposure can also cause changes in HRV, we have chosen HRV as our primary endpoint. We hypothesize that the imbalance between the sympathetic and the parasympathetic nervous system caused by chronic stress will result in altered responses to ozone exposure that will be reflected by HRV.

研究の種類

介入

入学 (実際)

40

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • North Carolina
      • Chapel Hill、North Carolina、アメリカ、27514
        • U.S. EPA Human Studies Facility

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~33年 (大人)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Healthy men and women between 18 and 33 years of age.

    1. 4-point Perceived Stress Symptom score <2 or >6
    2. Physical conditioning allowing intermittent, moderate exercise for two hours.
    3. Ability to complete the exposure exercise regimen without reaching 80% of predicted maximal heart rate.

      Predicted maximal heart rate will be calculated using the equation (described by Tanaka et al. [2001] J. Am. Coll. Cardiol.): [208bpm-((0.7) x (age in years))]

    4. Normal baseline 12-lead resting EKG, or if the automated reading is not normal the EKG must be approved by a study cardiologist.
    5. Normal lung function Forced vital capacity (FVC) ≥ 80% of that predicted for gender, ethnicity, age and height (according to NHANESIII guidelines).

      Forced expiratory volume in one second (FEV1) ≥ 80%of that predicted for gender, ethnicity, age and height.

      FEV1/FVC ratio ≥ 80% of predicted values.

    6. Oxygen saturation ≥ 96% on room air.

Exclusion Criteria:

  • . Individuals with a history of acute or chronic cardiovascular disease, chronic respiratory disease, diabetes, rheumatologic diseases, or immunodeficiency state.

    2. Individuals with a Framingham risk score (Hard Coronary Heart Disease; HCHD; 10-year risk) ≥10.

    3. Individuals with asthma or a history of asthma. 4. Individuals who are allergic to chemical vapors or gases. 5. Females who are pregnant, attempting to become pregnant, or breastfeeding. 6. Individuals that are unwilling or unable to stop taking vitamin C or E, or medications that may impact the results of ozone challenge such at least two weeks prior to the study and for the duration of the study. Medications not specifically mentioned here may be reviewed by the investigators prior to an individual's inclusion in the study.

    7. Individuals who have smoked tobacco during the last five years or those with a history of >5 pack years.

    8. Individuals living with a smoker who smokes inside the house. 9. Individuals with a body mass index (BMI) >35 or <18. Body mass index is calculated by dividing the weight in kilograms by the square of the height in meters.

    10. Individuals with occupational exposures to high levels of vapors, dust, gases, or fumes on an on-going basis.

    11. Individuals with uncontrolled hypertension (≥150 systolic or ≥90 diastolic).

    12. Individuals that do not understand or speak English. 13. Individuals that are unable to perform the exercise required for the study. 14. Individuals that are taking beta blocker medications. 15. Individuals with a history of skin allergies to adhesives used in securing EKG electrodes.

    16. Individuals with unspecified diseases, conditions, or medications that might influence the responses to the exposures, as judged by the medical staff.

    17. Individuals that are unwilling or unable to stop taking over-the-counter pain medications such as aspirin, ibuprofen (Advil, Motrin), naproxen (Aleve), or other non-steroidal anti-inflammatory ("NSAID") medications for 48 hours prior to the exposures and post-exposure visits.

    18. Individuals that are taking systemic steroids or beta-blocker medications. 19. Individuals with a hemoglobin A1c (HbA1c) level > 6.4%.

Temporary Exclusion Criteria

  1. Individuals with active seasonal allergies during the time of participation in the study.
  2. Individuals suffering from acute respiratory illness within four weeks prior to any of the study exposure series.
  3. Individuals that have been exposed to smoke and fumes within 24 hours of any study visit.
  4. Individuals that have consumed alcohol within 24 hours of any study visit.
  5. Individuals that have engaged in strenuous exercise within 24 hours of any study visit.
  6. Individuals that have been exposed to ozone-based home air purifiers within 24 hours of any study visit.
  7. Individuals that have been exposed to unvented household combustion sources (gas stoves, lit fireplaces, oil/kerosene heaters) within 48 hours of any study visit.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:基礎科学
  • 割り当て:ランダム化
  • 介入モデル:クロスオーバー割り当て
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
実験的:オゾン
オゾンへの暴露は、UNC キャンパスの EPA 人間研究施設の暴露室で行われます。
Each subject will be exposed up to 0.3ppm ozone for 2 hours. Subjects will exercise on a bike or treadmill. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/min/m2BSA followed by a 15 minute rest period.
他の名前:
  • O3
偽コンパレータ:きれいな空気
きれいな空気への曝露は、UNC キャンパスにある EPA 人間研究施設の曝露チャンバーで行われます。
Each subject will be exposed to clean air for 2 hours. Subjects will exercise on a bike or treadmill. Each exercise session will consist of a 15 minute exercise interval at a level of up to 25 L/min/m2BSA followed by a 15 minute rest period.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
心拍数変動の変化
時間枠:曝露前から曝露後24時間まで
対象者が事前に 20 分間休んでいた場合の 10 分間の心電図記録 (ホルター ECG によって測定)。 Mortara H12+ 12 リード ECG レコーダー (Mortara Instrument, Inc.、ウィスコンシン州ミルウォーキー) で収集されました。 デジタル記録された ECG は 180 Hz でサンプリングされます。
曝露前から曝露後24時間まで

二次結果の測定

結果測定
メジャーの説明
時間枠
最初の 1 秒間の強制呼気量 (FEV1)
時間枠:曝露前から曝露後24時間まで
最初の 1 秒間の強制呼気量 (FEV1) は、コンピューターに接続されたドライシール肺活量計で実行される肺活量測定によって決定されます。
曝露前から曝露後24時間まで
凝固・凝固因子の指標
時間枠:曝露前から曝露後24時間まで
凝固/凝固因子の指数は、オゾンと清浄空気に曝露した後の、血液中の凝固/凝固因子 (d-ダイマー、PA-1、tPA、vWillebrand 因子、およびプラスミノーゲン) のバスケットの平均変化率です。
曝露前から曝露後24時間まで
炎症マーカーのインデックス
時間枠:曝露前から曝露後24時間まで
炎症マーカーの指標は、オゾンと清浄空気への曝露後の血液中の全身性炎症に関連する因子 (IL-6、IL-8、TNF-a、IL-b、CRP) のバスケットの平均変化率です。
曝露前から曝露後24時間まで
強制肺活量
時間枠:曝露前から曝露後24時間まで
努力肺活量(FVC)は、コンピューターに接続されたドライシール肺活量計で実行される肺活量測定によって決定されます。
曝露前から曝露後24時間まで
Cortisol
時間枠:Pre exposure to 24hours post exposure
The mean % change of cortisol levels in the blood following exposure to ozone vs. clean air.
Pre exposure to 24hours post exposure
Cognitive function performance
時間枠:Pre exposure to 24hours post exposure
Index of cognitive function tests measured using six tests of the Cantab Research Suite (Reaction Time Test (RTI), Attention Switching Task (AST), Spatial Working Memory (SWM), Paired Associate Learning (PAL), Rapid Visual Information Processing (RVP), and Stop Signal Task (SST)) following exposure to ozone vs. clean air.
Pre exposure to 24hours post exposure

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:David Diaz-Sanchez, PhD、U.S. Environmental Protection Agency

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

便利なリンク

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始

2014年7月1日

一次修了 (実際)

2016年9月1日

研究の完了 (実際)

2017年1月1日

試験登録日

最初に提出

2014年7月30日

QC基準を満たした最初の提出物

2014年7月30日

最初の投稿 (見積もり)

2014年8月1日

学習記録の更新

投稿された最後の更新 (実際)

2017年7月26日

QC基準を満たした最後の更新が送信されました

2017年7月25日

最終確認日

2017年7月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • # 13-1644

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する